Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check54 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check68 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check75 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check90 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check97 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.9%
Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.